Renée W. Hockaday
PHA Communications
240-485-0774 ph.

Washington University School of Medicine’s Dr. Murali Chakinala Receives Outstanding Physician Award from Pulmonary Hypertension Association

Silver Spring, Md. (June 26, 2014) – The Pulmonary Hypertension Association (PHA), the nation’s leading pulmonary hypertension organization, presented Murali Chakinala, MD, FCCP, with its Outstanding Physician Award during PHA’s 11th Biennial International PH Conference and Scientific Sessions June 20-22, 2014. Conference helps to foster networking and bring hope to patients, caregivers and medical professionals working to live with and find a cure for pulmonary hypertension – a disease of the lungs that affects the functioning of the heart and can lead to right heart failure. Without treatment, mean survivability is only 2.8 years.

The Outstanding Physician Award recognizes a physician who has been most notable in his or her service to PHA and in promoting excellent clinical care, research, education and advocacy on behalf of PH patients. Dr. Chakinala first became acquainted with PH in the late 1990s, during his training to become a lung transplant physician at Washington University. He is a member of PHA's Scientific Leadership Council (SLC) and has served as chair of the PHA 30-City Medical Education Program Planning Committee and as the 2011 PHA on the Road: PH Patients and Families Education Forum Regional Committee Chair for St. Louis. Most recently, he has spearheaded PHA's Pulmonary Hypertension Care Centers (PHCC) initiative and is the chair of the PHCC Committee. This initiative is a groundbreaking accreditation program for PH centers, designed to improve quality of care in the field.

"Past winners of this award include many of those who have built the field from one with little interest to one that now has as many or more treatments than all but two of the 7,000 identified rare diseases," said Rino Aldrighetti, President and CEO of PHA. "Dr. Chakinala, through his work with the PH Care Centers, has been instrumental in creating a game-changer for improved treatment of patients. He has led the effort to move the PH Care Centers from an idea to reality in less than three years. It is an extraordinary achievement."

About the Pulmonary Hypertension Association
Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country's leading pulmonary hypertension organization. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, research, advocacy and awareness. PHA does this by connecting and working together with the entire PH community of patients, families and medical professionals. PHA facilitates more than 245 support groups around the country and delivers continuing education for medical professionals.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Terms of Use    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.

BBB Accredited Charity BEST in AmericaCharity Navigator

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.